Literature DB >> 28893806

Low-dose intrapleural alteplase (without deoxyribonuclease) in complicated parapneumonic effusion: case series and literature reviews.

Carol Lai1, Nurashikin Mohammad2, Tidi Maharani Hassan1, Mohamed Faisal Abdul Hamid1,1.   

Abstract

This case series reviews two cases of elderly patients who presented with fever, cough and shortness of breath. Clinical examinations and initial chest radiographs confirmed unilateral pleural effusion. Thoracenteses were consistent with exudative pleural effusion. We commenced intravenous antibiotics treating for parapneumonic effusions. The first case showed persistent effusion despite drainage, and the second case had a little aspirate from pleural tapping. Subsequent ultrasound of the thorax showed multiloculated effusions. We made the decisions for intrapleural fibrinolytic therapy using low-dose alteplase 2.5 mg each time, in view of the elderly patient as sacrosanct for risk of bleeding. Furthermore, DNase was not used, as it is not yet available in our setting. Both of our patients had good clinical and radiological outcomes, without the need for surgical interventions. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  drugs and medicines; respiratory system

Mesh:

Substances:

Year:  2017        PMID: 28893806      PMCID: PMC5604701          DOI: 10.1136/bcr-2017-221239

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection.

Authors:  Francesco Piccolo; Natalia Popowicz; Donny Wong; Yun Chor Gary Lee
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

2.  The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema.

Authors:  R W Light; T Nguyen; M E Mulligan; S A Sasse
Journal:  Lung       Date:  2000       Impact factor: 2.584

Review 3.  Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.

Authors:  R Cameron; H R Davies
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

4.  Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema.

Authors:  George Thommi; Chandra K Nair; Wilbert S Aronow; Chris Shehan; Patrick Meyers; Matthew McLeay
Journal:  Am J Ther       Date:  2007 Jul-Aug       Impact factor: 2.688

5.  Parapneumonic effusions.

Authors:  R W Light; W M Girard; S G Jenkinson; R B George
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

6.  Intrapleural use of tissue plasminogen activator and DNase in pleural infection.

Authors:  Najib M Rahman; Nicholas A Maskell; Alex West; Richard Teoh; Anthony Arnold; Carolyn Mackinlay; Daniel Peckham; Chris W H Davies; Nabeel Ali; William Kinnear; Andrew Bentley; Brennan C Kahan; John M Wrightson; Helen E Davies; Clare E Hooper; Y C Gary Lee; Emma L Hedley; Nicky Crosthwaite; Louise Choo; Emma J Helm; Fergus V Gleeson; Andrew J Nunn; Robert J O Davies
Journal:  N Engl J Med       Date:  2011-08-11       Impact factor: 91.245

7.  Two sequential tPA/DNase courses for noncommunicating loculated collections in pleural infection.

Authors:  Natalia Popowicz; Francesco Piccolo; Ranjan Shrestha; Y C Gary Lee
Journal:  Respirol Case Rep       Date:  2014-05-04

8.  Unintentional intramuscular administration of tPA/DNase for pleural infection.

Authors:  Natalia Popowicz; Michael Nash; Y C Gary Lee
Journal:  Respirol Case Rep       Date:  2014-10-10

9.  Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions--analysis of predictors for failure of therapy and bleeding: a cohort study.

Authors:  Saleh Abu-Daff; Donna E Maziak; Derar Alshehab; Jennifer Threader; Jelena Ivanovic; Valerie Deslaurier; Patrick-James Villeneuve; Sebastian Gilbert; Sudhir Sundaresan; Farid Shamji; Colleen Lougheed; Jean M Seely; Andrew J E Seely
Journal:  BMJ Open       Date:  2013-01-31       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.